Report #2850188

Received Jul 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: KS
Recovered: Unknown
Vaccinated: Jul 14, 2025
Onset: Jul 14, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	—	—

Symptoms (1)

Extra dose administered

Symptom narrative

Shingrix third dose administered; This non-serious case was reported by a consumer via sales rep and described the occurrence of extra dose administered in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received 2 doses in 2019). On 14-JUL-2025, the patient received the 3rd dose of Shingrix. On 14-JUL-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Shingrix third dose administered). The outcome of the extra dose administered was not applicable. Additional Information: GSK Receipt Date: 14-JUL-2025 The reporter reported that a patient completed 2 doses of Shingrix in 2019 and vaccine coordinator accidentally gave patient 3rd dose of Shingrix today, which led to extra dose administered.